Juvenescence Ltd Age X Therapeutics, Inc. (AGE) insider trading activity
Juvenescence LTD is Director of AgeX Therapeutics, Inc.. Currently has a direct ownership of 0 shares of AGE, which is worth approximately $0. The most recent transaction as insider was on Mar 14, 2023, when has been sold 16,447,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
0%
12M change
Total Value Held
$0
JL
Juvenescence LTD
Director
Ramsey, Y8